| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC10243 | 2,2′-Dihydroxy-4-methoxybenzophenone | Dioxybenzone (benzophenone-8) is an organic compound used in sunscreen to block UVB and short-wave UVA (ultraviolet) rays |
|
| DC26047 | Dipeptide diaminobutyroyl benzylamide (acetate) Featured | Dipeptide diaminobutyroyl benzylamide is a biomimetic peptide and a muscarinic acetylcholine receptor antagonist. |
|
| DCAPI1582 | Diphenhydramine Citrate | Diphenhydramine Citrate |
|
| DCAPI1072 | Diphenhydramine HCl (Benadryl) | Diphenhydramine HCl (Benadryl) |
|
| DC23591 | Diphyllin | Diphyllin is a naturally potent vacuolar ATPase (v-ATPase) inhibitor with IC50 of 17 nM, potently inhibits the acid influx with IC50 of 0.6 nM. |
|
| DC12269 | Diprotin A TFA (Ile-Pro-Pro (TFA)) | Diprotin A (TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV). |
|
| DC26059 | Diprotin A Featured | Diprotin A is a tripeptide inhibitor of dipeptidyl peptidase 4 |
|
| DC11244 | Diprovocim | Diprovocim is a potent human and mouse Toll-like receptor (TLR)1/TLR2 agonist. |
|
| DCAPI1267 | Dipyridamole (Persantine) | Dipyridamole (Persantine) |
|
| DC10343 | Diquafosol tetrasodium Featured | Diquafosol tetrasodium is a P2Y2 receptor agonist that stimulates fluid and mucin secretion on the ocular surface, as a topical treatment of dry eye disease. |
|
| DC23302 | Disarib Featured | Disarib is a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain, demonstrates strong affinity to BCL2, but not to other antiapoptotic BCL2 family members(BCL-xL, BCL2A1 etc.). |
|
| DC22511 | Disitertide | Disitertide (P144) is a TGF-β1 antagonist peptide. |
|
| DCAPI1398 | Disulfiram (Antabuse) Featured | Disulfiram (Antabuse) |
|
| DCAPI1335 | Divalproex sodium | Divalproex sodium |
|
| DC23122 | DiZPK Featured | DiZPK is a genetically encoded, highly efficient photocrosslinking amino acid valuable in unveiling the physiological interaction partners of given proteins and their functions.. |
|
| DC22216 | DJ4 Featured | DJ4 (ROCK inhibitor DJ4) is a potent, selective, ATP-competitive inhibitor of ROCK1/2 and MRCKα/β with IC50 of 5/50 nM and 10/100 nM, respectively. |
|
| DC12040 | DJ-V-159 Featured | DJ-V-159 is an agonist for G protein-coupled receptor family C group 6 member A (GPRC6A). |
|
| DC12442 | DK419 Featured | DK419 (DK-419) a potent, orally acitve inhibitor of Wnt/β-catenin signaling with IC50 of 0.19 uM in Wnt3A-stimulated TOPFlash assays. |
|
| DC12431 | DKFZ-251 | DKFZ-251 (DKFZ251) is a selective inhibitor of Kallikrein-related peptidase 6 (KLK6) with IC50 of 0.13 uM, demonstrates good selectivity for KLK6 compared to other KLKs. |
|
| DC12404 | DKFZ-633 | DKFZ-633 (DKFZ633) is a selective inhibitor of Kallikrein-related peptidase 6 (KLK6) with IC50 of 0.25 uM, demonstrates good selectivity for KLK6 compared to other KLKs. |
|
| DC10550 | DKM 2-93 Featured | DKM 2-93 is a relatively selective inhibitor of UBA5 with an IC50 of 430 μM. |
|
| DC10707 | DL-AP4 Featured | DL-AP4 is a Broad spectrum EAA antagonist. |
|
| DC20363 | DL-AP4 sodium salt | DL-AP4 sodium salt is a broad spectrum glutamate receptor antagonist.. |
|
| DC10708 | DL-AP5 Featured | DL-AP5 is a Broad spectrum EAA antagonist. |
.gif)
|
| DC10709 | DL-AP5 Sodium salt Featured | DL-AP5 is a Broad spectrum EAA antagonist. |
.png)
|
| DCAPI1183 | DL-Carnitine HCl | DL-Carnitine HCl |
|
| DC11486 | D-Luciferin (potassium salt) Featured | D-Luciferin is a chemiluminescent substrate of firefly luciferase. |
|
| DC9287 | D-Luciferin Featured | D-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP, used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications. Cas: 2591-17-5 |
|
| DC11426 | DM1-PEG4-DBCO Featured | DM1-(PEG)4-DBCO (DBCO-PEG4-DM1) is made by DM1 conjugated to DBCO-(PEG)4 linker.DM1 (mertansine), a thiol-containing maytansinoid, is a potent microtubule-disrupting agent. |
|
| DC11396 | DM1-SMe Featured | DM1-SMe is a potent maytansinoid microtubular inhibitor and an unconjugated DM1 as a mixed disulfide with thiomethane to cap its sulfhydryl group. |
|
